Sarepta Therapeutics | Attività

Prezzo Delle Azioni
20.20
Cambio Giornaliero
-0.08 -0.39%
Mensile
-4.13%
Annuale
-83.03%
Q1 Previsione
19.71




Attività Cambiamento Data
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Amgen USD 90.14B 2.24B 2025-09
Biogen USD 29.21B 877.3M 2025-09
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 114.94B 14.01B 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
Incyte USD 6.33B 509M 2025-09
Insmed USD 2.36B 119.12M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Moderna USD 12.14B 125M 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Tectonic Therapeutic USD 277M 18.31M 2025-09
Ultragenyx Pharmaceutical USD 1.19B 115.82M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


Sarepta Therapeutics Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.